drug
octreotide acetate LA
Marketedupdated 3mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- drugoctreotide LA4 co-mentions · 4 sources
- drugoctreotide acetate4 co-mentions · 4 sources
- drugBynfezia4 co-mentions · 4 sources
- drugoctreotide acetate DR4 co-mentions · 4 sources
- companyTeva Pharmaceuticals USA Inc3 co-mentions · 3 sources
- tagRecall3 co-mentions · 3 sources
- tagApproval2 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying octreotide acetate LA
- phase3Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
- phase1A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
- phase2A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
- phase4Effects of Sandostatin LAR® in Acromegaly
- phase1A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that